Sponsor intelligence · INDUSTRY
Clinical trials sponsored by
Guangdong Hengrui Pharmaceutical Co., Ltd.
Real, source-linked trial activity for Guangdong Hengrui Pharmaceutical Co., Ltd: 3 tracked trials, by phase and status, newest first. New trials = pipeline expansion = CRO, site, and reagent demand.
✔ Verified against the public NIH RePORTER & ClinicalTrials.gov records as of Sep 19, 2026. Source-linked, daily-refreshed.
PHASE1 2PHASE2 1
Newest Guangdong Hengrui Pharmaceutical Co., Ltd trials
| Posted | Trial | Phase | Status | |
|---|---|---|---|---|
| 3d ago | A Randomized, Double-Blind, Dose-Escalation, Placebo-Controlled Study | Ph 1 | NOT_YET_RECRUITING | ↗ |
| 40d ago | A Study to Evaluate the Safety of SHR-7590 in Chinese Healthy Particip | Ph 1 | NOT_YET_RECRUITING | ↗ |
| 40d ago | A Phase II Clinical Study to Evaluate the Efficacy and Safety of SHR-1 | Ph 2 | NOT_YET_RECRUITING | ↗ |
Get this lane pushed to you the day a new grant or trial lands
Free email digest + a daily new-funding feed (JSON / MCP / webhook) of newly-awarded NIH grants and newly-registered clinical trials for Guangdong Hengrui Pharmaceutical Co., Ltd (trial sponsor). Watch institutions, PIs, sponsors, and topics. Newly-funded labs = new buyers, today.